Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer

NCT02600949 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Adenocarcinoma
Metastatic Pancreatic Ductal Adenocarcinoma
Stage IV Colorectal Cancer AJCC v7
Stage IV Pancreatic Cancer AJCC v6 and v7
Stage IVA Colorectal Cancer AJCC v7
Stage IVB Colorectal Cancer AJCC v7

Interventions

DRUG: Imiquimod
BIOLOGICAL: Pembrolizumab
BIOLOGICAL: Sotigalimab
BIOLOGICAL: Synthetic Tumor-Associated Peptide Vaccine Therapy
PROCEDURE: Computed Tomography
PROCEDURE: Magnetic Resonance Imaging

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]